CME Group Inc. (CME) Given Average Rating of “Hold” by Analysts
CME Group Inc. (NASDAQ:CME) has been given a consensus recommendation of “Hold” by the thirteen brokerages that are presently covering the firm. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating and five have given a buy rating to the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $102.21.
CME has been the subject of several research reports. Jefferies Group increased their price objective on CME Group from $112.00 to $118.00 and gave the company a “buy” rating in a report on Wednesday, August 31st. Deutsche Bank AG increased their price objective on CME Group from $115.00 to $116.00 and gave the company a “buy” rating in a report on Wednesday, October 5th. JPMorgan Chase & Co. set a $116.00 price objective on CME Group and gave the company a “buy” rating in a report on Monday, September 12th. Zacks Investment Research raised CME Group from a “sell” rating to a “hold” rating in a report on Thursday, June 30th. Finally, Barclays PLC reduced their price objective on CME Group from $100.00 to $99.00 and set an “equal weight” rating for the company in a report on Friday, July 29th.
In other news, CEO Phupinder Gill sold 30,002 shares of the firm’s stock in a transaction dated Monday, September 19th. The stock was sold at an average price of $110.00, for a total transaction of $3,300,220.00. Following the transaction, the chief executive officer now directly owns 116,222 shares of the company’s stock, valued at $12,784,420. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Hilda Harris Piell sold 893 shares of the firm’s stock in a transaction dated Monday, September 19th. The shares were sold at an average price of $110.00, for a total value of $98,230.00. Following the transaction, the insider now directly owns 29,125 shares in the company, valued at $3,203,750. The disclosure for this sale can be found here. 0.61% of the stock is owned by corporate insiders.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/10/12/cme-group-inc-cme-given-average-rating-of-hold-by-analysts.html
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Hudock Capital Group LLC boosted its position in shares of CME Group by 0.7% in the second quarter. Hudock Capital Group LLC now owns 3,706 shares of the company’s stock worth $360,000 after buying an additional 24 shares during the period. Windward Capital Management Co. CA boosted its position in shares of CME Group by 1.0% in the second quarter. Windward Capital Management Co. CA now owns 2,626 shares of the company’s stock worth $256,000 after buying an additional 25 shares during the period. Gofen & Glossberg LLC IL boosted its position in shares of CME Group by 0.4% in the second quarter. Gofen & Glossberg LLC IL now owns 7,323 shares of the company’s stock worth $713,000 after buying an additional 26 shares during the period. Beacon Financial Group boosted its position in shares of CME Group by 0.8% in the second quarter. Beacon Financial Group now owns 4,525 shares of the company’s stock worth $435,000 after buying an additional 38 shares during the period. Finally, Pekin Singer Strauss Asset Management IL boosted its position in shares of CME Group by 0.3% in the second quarter. Pekin Singer Strauss Asset Management IL now owns 13,811 shares of the company’s stock worth $1,345,000 after buying an additional 39 shares during the period. 80.29% of the stock is currently owned by hedge funds and other institutional investors.
Shares of CME Group (NASDAQ:CME) traded up 0.38% during trading on Wednesday, hitting $104.32. The stock had a trading volume of 400,192 shares. CME Group has a 1-year low of $81.87 and a 1-year high of $110.35. The firm’s 50 day moving average is $106.59 and its 200 day moving average is $99.56. The company has a market cap of $35.35 billion, a PE ratio of 26.34 and a beta of 0.83.
CME Group (NASDAQ:CME) last released its earnings results on Thursday, July 28th. The company reported $1.14 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.11 by $0.03. The company earned $906 million during the quarter, compared to analyst estimates of $897.84 million. CME Group had a return on equity of 6.83% and a net margin of 38.22%. CME Group’s quarterly revenue was up 10.5% on a year-over-year basis. During the same period in the prior year, the company posted $0.95 earnings per share. Equities research analysts anticipate that CME Group will post $4.43 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Monday, September 26th. Investors of record on Friday, September 9th were paid a $0.60 dividend. The ex-dividend date of this dividend was Wednesday, September 7th. This represents a $2.40 dividend on an annualized basis and a yield of 2.31%. CME Group’s dividend payout ratio is presently 60.61%.
CME Group Company Profile
CME Group Inc is a provider of products across all major asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. The Company’s products include both exchange-traded and privately negotiated futures and options contracts and swaps. The Company connects buyers and sellers together through its CME Globex electronic trading platform across the globe and its open outcry trading facilities in Chicago and New York City.
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.